Plant upgrade to lower supply of Merck's adult HBV shot

01/7/2009 | Philadelphia Inquirer, The

Merck & Co. announced an impending shortage of the adult version of Recombivax HB, its hepatitis B vaccine, because of improvements to its West Point, Pa., facility. The shortfall does not include the pediatric formulation and is not linked to an FDA warning issued in April about production issues at the plant, a Merck spokeswoman said. GlaxoSmithKline is making enough vaccines to address the shortage, the CDC said.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC